EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis

Do Hyeon Kim, Kye Hoon Park, Yun Jin Kang

The Journal of International Advanced Otology · 2024

DOI: 10.5152/iao.2024.231374 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of International Advanced Otology, 2024. Verfasst von Do Hyeon Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea. Hauptthemen laut MEDLINE: Biological Therapy, Eosinophilia, Otitis Media. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Eosinophilic otitis media, first reported in Japan, is a viscous, intractable otitis media often linked to bronchial asthma and chronic rhinosinusitis, characterized by highly viscous middle ear effusion. Its pathological mechanism remains unclear and the condition occasionally does not respond to steroids. It is now recognized as a rare type 2 inflammatory disease and should be treated specifically to enhance quality of life. This systematic review and meta-analysis evaluated the efficacies of biologic treatments.

Methods

We searched PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases up to September 2023. We retrieved ear examination findings, otitis media-related and symptom scores, air–bone gaps and hearing thresholds, serum eosinophil, and immunoglobulin E (IgE) levels before and after biologic treatments.

Results

Biologics treatment significantly improved subjective otitis media-related scores, compared with control group (standard mean difference (SMD) −1.62; 95% confidence interval (CI) [−2.24; −1.01], I2=54%). Additionally, the serum eosinophil counts and IgE levels significantly decreased (SMD −1.40; 95% CI [−1.99; −0.81], I 2=0%) after 6-12 months of biologic treatments, but the hearing thresholds did not significantly change. There were no significant differences between groups treated with dupilumab and groups treated with other biologics.

Conclusion

Biologics treatment for eosinophilic otitis media significantly improved subjective otitis media-related scores and decreased serum eosinophil and IgE levels, but no significant changes in hearing threshold. More randomized cohort studies are needed to confirm the efficacies of biologics in patients with refractory eosinophilic otitis media. Cite this article as: Kim DH, Park KH, Kang YJ. Efficacy of biologic therapies for eosinophilic otitis media: A systematic review and meta-analysis. J Int Adv Otol. 2024;20(4):331-338.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological TherapyEosinophiliaOtitis MediaHumansAntibodies, Monoclonal, HumanizedBiological ProductsEosinophilsImmunoglobulin EOtitis Media with EffusionQuality of LifeTreatment Outcome

Substanzen

Antibodies, Monoclonal, HumanizedBiological ProductsdupilumabImmunoglobulin E

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea.

Zitieren

APA

Kim, D. H., Hoon Park, K., & Jin Kang, Y. (2024). Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis. The Journal of International Advanced Otology. https://doi.org/10.5152/iao.2024.231374

Vancouver

Kim DH, Hoon Park K, Jin Kang Y. Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis. The Journal of International Advanced Otology. 2024. doi:10.5152/iao.2024.231374

BibTeX
@article{Kim2024,
  author = {Kim, Do Hyeon and Hoon Park, Kye and Jin Kang, Yun},
  title = {Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis},
  journal = {The Journal of International Advanced Otology},
  year = {2024},
  doi = {10.5152/iao.2024.231374}
}
Kostenlos starten →